Content overview
Basic principle
Performance data
Resources
Products
Content
- Basic principle
- Performance data
- Resources
- Products
Content overview
Basic principle
Performance data
Resources
Products
REAlease® Releasable Antibodies allow for the removal of any labels from cells after cell sorting in just one simple step.
The technology relies on recombinantly engineered antibody fragments that are, unlike conventional antibodies, characterized by low epitope binding affinities.
A novel covalent conjugation approach allows for multimerization and fluorescent labeling of these antibody fragments. They form the so called REAlease Fluorochrome Complex which facilitates high-avidity cell binding that is comparable to conventional fluorochrome conjugates.
This novel and innovative conjugation chemistry allows for fast removal of the REAlease Fluorochrome Complex from the cell surface by adding the REAlease Release Reagent after cell sorting. This leads to disruption of the complex and thereby results in monomerization of the antibody fragments.
Due to their engineered low binding affinity, they spontaneously dissociate from the cell surface.
As a result, label-free cells can be obtained after cell sorting providing maximal flexibility for a wide range of applications.
The staining performance of REAlease Antibodies is equivalent to conventional antibodies with comparable brightness and low non-specific binding.
The removal of REAlease Antibodies is highly efficient and selective with no detectable fluorescence signal remaining after the release step.
Additionally, the labeling efficiency in the relabeling step is equivalent to the initial staining demonstrating that epitopes become completely available again.
For release and relabel with REAlease Antibodies refer to the REAlease Support Kit.
The new covalent conjugation chemistry of the fluorochrome conjugates allows a reversible multi-parameter cell labeling.
To demonstrate the versatility of this technology, we developed REAlease Fluorochrome Conjugates for several cell markers that can be used for multiparameter panel stainings of e.g. pan T cells.
In this example, five-parameter cell labeling of peripheral blood mononuclear cells (PBMCs) with REAlease Fluorochrome Conjugates allows for clear definition and discrimination of T cell subsets.
After the addition of the REAlease Release Reagent all fluorochrome conjugates can efficiently be released.
Our REAlease® Releasable Antibodies were awarded with the technology prize at the Pharmaceutical Flow Cytometry & Imaging 2018 conference in Stevenage, UK. Delegates of the European Laboratory Research & Innovation Group (ELRIG) nominated our technology, underlining its importance for biotechnology and pharmaceutical research.
In just one simple step, REAlease Releasable Antibodies allow for the removal of any labels from cells after cell sorting. Watch this video to find out step-by-step how the technology works and how you can use it to be more flexible in your downstream applications after cell sorting.
139 products found
|
You have previously chosen International as your location.
What do you want to do?